Ancient DNA study provides information about origin of Justinianic Plague

NewsGuard 100/100 Score

Ancient DNA analyses of skeletal remains of plague victims from the 6th century AD provide information about the phylogeny and the place of origin of this pandemic

From the several pandemics generally called 'pestilences' three are historically recognized as due to plague, but only for the third pandemic of the 19th to 21st centuries AD there were microbiological evidences that the causing agent was the bacterium Yersinia pestis. "For a long time scholars from different disciplines have intensively discussed about the actual etiological agents of the past pandemics. Only ancient DNA analyses carried out on skeletal remains of plague victims could finally conclude the debate", said Dr. Barbara Bramanti of the Palaeogenetics Group at the Institute of Anthropology at Johannes Gutenberg University Mainz (JGU). About two years ago, she headed the international team which demonstrated beyond any doubt that Y. pestis also caused the second pandemic of the 14th-17th centuries including the Black Death, the infamous epidemic that ravaged Europe from 1346 to 1351. Bramanti and her Mainz colleague Stephanie H-nsch now cooperated with the University of Munich, the German Bundeswehr, and international scholars to solve the debate as to whether Y. pestis caused the so-called Justinianic Plague of the 6th to 8th centuries AD. The results of ancient DNA analyses carried out on the early medieval cemetery of Aschheim in Bavaria were published last week in PloS Pathogens. They confirmed unambiguously that Y. pestis was indeed the causing agent of the first pandemic, in contrast to what has been postulated by other scientists recently. This revolutionary result is supported by the analysis of the genotype of the ancient strain which provide information about the phylogeny and the place of origin of this plague. As for the second and third pandemic, the original sources of the plague bacillus were in Asia.

"It remains questionable whether at the time of the Byzantine Emperor Justinian only one strain or more were disseminated in Europe, as it was at the time of the Black Death," suggested Bramanti and H-nsch. To further investigate this and other open questions about the modalities and route of transmission of the medieval plagues, Bramanti has recently obtained an ERC Advanced Grant for the project "The medieval plagues: ecology, transmission modalities and routes of the infection" (MedPlag) and will move to the Center for Ecological and Evolutionary Synthesis (CEES) at the University of Oslo in Norway. The CEES, chaired by Nils Chr. Stenseth, has an outstanding and rewarded record of excellence in the research on infectious diseases and in particular on Y. pestis. The MedPlag research group is constituted by Stephanie H-nsch, Lars Walloe, Boris Schmid, Kyrre L. Kausrud and Ryan W. Easterday (University of Oslo, Norway), Mark Achtman (University of Warwick, UK), Elisabeth Carniel (Institute Pasteur, Paris, France), Raffaella Bianucci (University of Turin, Italy), Ulf B-ntgen (Swiss Federal Research Institute for Forest, Snow and Landscape, Switzerland) as well as celebrated historians and archaeologists from Europe, Asia, and America.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Tracking circulating tumor DNA could indicate gastroesophageal cancer treatment response